Axavive has introduced a plant-based skin support supplement featuring Astragaloside IV, a compound derived from Astragalus membranaceus, aimed at promoting collagen wellness, antioxidant defense, and skin hydration. The formula includes six botanical ingredients designed to support skin structure, elasticity, and cellular repair pathways. While ingredient-level research supports the potential benefits of Astragaloside IV, no clinical trials on the finished product exist, and the supplement is not FDA-approved to treat or prevent aging. Axavive is manufactured in the USA under GMP standards, sold exclusively online starting at $158, and comes with a 90-day money-back guarantee for customer assurance.
Alstom and its consortium partners have reached financial close for the Haifa-Nazareth light rail project in Israel, a major step enabling full-scale execution. The €2 billion project will build a 41-kilometer light rail line connecting Haifa, Nazare...
Alstom and its partners have finalized financing for the Haifa-Nazareth light rail project in Israel, valued at around €2 billion, with Alstom's share at approximately €750 million. The 41-kilometer line will connect Haifa, Nazareth, and nearby commu...
The global strategy consulting market, valued at $81.51 billion in 2025, is projected to grow to $194.56 billion by 2035 with a CAGR of 9.09%. Growth is fueled by increasing demand for digital transformation, AI-powered advisory services, ESG consult...
The global pharmaceutical surfactants market, valued at $4.5 billion in 2025, is projected to grow to $6.93 billion by 2035 at a CAGR of 4.42%. Growth is fueled by increasing use in drug formulation to enhance solubility, stability, and bioavailabili...
Bitcoin has rebounded from its Asian session lows, trading around $63,500 despite a nearly 3% drop over the past 24 hours. This recovery comes as Nasdaq futures fell to their lowest level since May, down 1.2% for the week, with significant declines i...
